DE
AZN icon

Day & Ennis’s AstraZeneca AZN Stock Holding History

Day & Ennis’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$215K Hold
1,596
– – 0.08% 115
2023
Q3 		$216K Hold
1,596
– – 0.08% 111
2023
Q2 		$228K Hold
1,596
– – 0.09% 104
2023
Q1 		$221K Hold
1,596
– – 0.08% 111
2022
Q4 		$216K Buy
+1,596
New +$200K 0.08% 108
2022
Q3 		– Sell
-1,596
Closed -$211K – 105
2022
Q2 		$211K Hold
1,596
– – 0.08% 108
2022
Q1 		$212K Buy
+1,596
New +$191K 0.07% 120

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Day & Ennis's AZN Position: Q4 2023 in Review

Day & Ennis held its AstraZeneca (AZN) position steady in Q4 2023 at 1,596 shares worth $215K. The position accounts for 0.08% of the portfolio, ranked #115.

Day & Ennis first reported a position in AZN in Q1 2022 and has held it in 7 quarters since. The position peaked at $228K in Q2 2023. 1,130 funds tracked by Wall St. Rank hold AZN as of Q4 2023.

  • Day & Ennis held 1,596 shares of AstraZeneca worth $215K as of Q4 2023.
  • Day & Ennis left its AstraZeneca share count unchanged in Q4 2023.
  • AstraZeneca made up 0.08% of Day & Ennis's portfolio in Q4 2023, its #115 holding.
  • Day & Ennis first reported a position in AstraZeneca in Q1 2022 and has held it in 7 quarters since.
  • Day & Ennis's AstraZeneca position peaked at $228K in Q2 2023.
  • 1,130 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2023.

Based on Day & Ennis's 13F filing for Q4 2023, filed 18 Jan 2024.